NDC 0053-0170-17
HEMGENIX
etranacogene dezaparvovec · KIT
Hemgenix is a gene therapy used to treat adults with severe hemophilia B, a bleeding disorder caused by deficiency of blood clotting factor IX. It works by delivering a functional copy of the gene needed to produce clotting factor, potentially reducing the need for factor replacement therapy.
Key Facts
- Brand Name
- HEMGENIX
- Generic Name
- etranacogene dezaparvovec
- NDC Code (Package)
0053-0170-17- NDC Code (Product)
0053-0170- Manufacturer
- CSL Behring
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125772
- Marketing Start
- 11/22/2022
Recall History
No Recall HistoryView Full Drug Page
HEMGENIX — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.